dc.contributor.author | Lawler, Grace | |
dc.contributor.author | Roche, Jim | |
dc.contributor.author | Brady, Damien | |
dc.contributor.author | Kealey, Carmel | |
dc.date.accessioned | 2022-02-28T10:58:11Z | |
dc.date.available | 2022-02-28T10:58:11Z | |
dc.date.copyright | 2022 | |
dc.date.issued | 2022 | |
dc.identifier.citation | Lawler, G., Roche, J., Brady, D., Kealey, C. (2022). Presented at TUS MMW Poster Presentation Seminar January 2022 | en_US |
dc.identifier.uri | http://research.thea.ie/handle/20.500.12065/3914 | |
dc.description.abstract | Aim: This research endeavour will determine
and evaluate the mechanism of action of a
modified coconut oil that has previously shown
promising antimicrobial activity against the
opportunistic infection, T. rubrum.
Background: Dermatophyte disorders are
among humanity’s most
persistent parasitic associates, and by now have
survived several generations of therapeutic
regimens. One concern in particular is the
clinical difficulty of obtaining permanent
treatments for fungal infections in the distal and
lateral subungual space of the human
nail. Another current worry remains the limited
number of antifungal treatments available on
the market, and with the widespread use of a
small selection of such agents, there is a fear of
a potential rise in antifungal resistance. These
issues highlight the demand for novel antifungal
therapeutic agents and with scaffolds offered by
nature becoming increasing popular,
they might just be the perfect solution
to combat the concerns. One such offering is
under development by a research group in TUS Midlands. | en_US |
dc.format | PDF | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Technological University of the Shannon Midlands Midwest | en_US |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Fungal infections | en_US |
dc.subject | Antifungal treatments | en_US |
dc.subject | Antifungal resistance | en_US |
dc.title | Fingerprinting critical therapeutic attributes: overcoming challenges to fulfil commercial potential – Early stages | en_US |
dc.type | info:eu-repo/semantics/other | en_US |
dc.contributor.affiliation | Technological University of the Shannon Midlands Midwest | en_US |
dc.identifier.orcid | https://orcid.org/ 0000-0003-2995-3000 | en_US |
dc.identifier.orcid | https://orcid.org/ 0000-0002-3648-3302 | en_US |
dc.identifier.orcid | https://orcid.org/ 0000-0003-4979-6241 | en_US |
dc.rights.accessrights | info:eu-repo/semantics/openAccess | en_US |
dc.subject.department | Faculty of Science & Health TUS Athlone Campus | en_US |
dc.type.version | info:eu-repo/semantics/publishedVersion | en_US |